Published on
Jul 22, 2025
Headlines – MS, Alzheimer’s, Flu Benefit, Tsunami Relief
MS FDA APPROVES NEW DRUG Following the first year of two ongoing clinical trials. the FDA has approved natalizumab, also known by the brand name Tysabri and previously known as Antegren, to reduce the frequency of clinical relapses in relapsing forms of …
Source:
ABILITY Magazine
-
Neutral
